|
| 'Chitosan (1) | 1 (2) | 1, 3, 4 - oxadiazoles (1) |
| 1,2,3,4-tetrahydro-9Hpyrido [3,4-b] indole-3-carboxylic acid (1) | 1,3,4-Oxadiazole (1) | 1,3,4-Oxadiazoles (1) |
| 1-butyl-3-methyl imidazolium bromide (1) | 1-butyl-3-methyl imidazolium chloride. (1) | 1-methyl-4-phenyl-1 (1) |
| 12-Dimethylbenz[a]anthracene (1) | 18 β-glycyrrhetic acid (1) | 2 (2) |
| 2, 5-diaza bicyclo [4.3.1] compounds (1) | 2,2-diphenyl-1-picrylhdrazyl (1) | 2-(N-hydroxymethyl amino)-indol-3-yl-propanoic acid (1) |
| 2-aminobenzothiazole (1) | 2-Hydroxypropyl-β-cyclodextrin (1) | 23 factorial design (1) |
| 25(OH)2D (1) | 3 (2) | 3-Methyl-2-benzothiazonium hydrazone hydrochloride (1) |
| 32 factorial design (1) | 3D QSAR (1) | 3D-QSAR (1) |
| 3’ UTR region (1) | 4 - acetamido phenoxy acetyl hydrazide (1) | 4-dihydroxy-4-methoxybenzophenone- 2-O-β-d-glucopyranoside (1) |
| 4-pyridinecarboxylic acid hydrazide (1) | 4-Thiadiazole-2-amine (1) | 5-fluoroindolin-2-one (1) |
| 5-Fluorouracil (1) | 5-HT 3 receptor antagonists (1) | 5-Piperazinedione (1) |
| 6 (1) | 6-beta naltrexol (2) | 6-Mercaptopurine (1) |
| 6-Methylmercaptopurine (1) | 6-tetrahydropyridine (MPTP) (1) | 7 (1) |
| 7-Hydroxy warfarin. (1) | 8-iso-Prostaglandin F2α (1) | 99mTc-ciprofloxacin (1) |
| A. nilotica (1) | ABC analysis (5) | ABC-VED matrix (4) |
| ABC-VEN analysis (1) | Abdominal Pregnancy (1) | Abheshaja (1) |
| Absorbance ratio (1) | Absorption ratio (1) | ABTS (1) |
| Abuse (1) | Academic Stressors scale (1) | Accuracy. (1) |
| Accurate (1) | ACE (2) | ACE inhibitor (1) |
| Aceclofenac (1) | ACEIs (1) | Acetaminophen (1) |
| Acetazolamide (1) | Acetic acid induced rat colitis (1) | acetic acid induced writhing test (1) |
| Acetyl cholinesterase estimation (1) | Acetyl isoniazid (1) | Acetylation rate (1) |
| Acetylcholinesterase (1) | Acetylcholinesterase inhibitors (1) | ACF (1) |
| Acid hydrolysis (1) | Acid violet 43 (1) | Acid-resistant capsules (1) |
| Acne (1) | Acne vulgaris (1) | Aconitine (1) |
| Acquired immune deÞ ciency syndrome (1) | Acrylamide grafted ghatti gum; Biodegradable; Diclofenac sodium; pH-sensitive hydrogel; Controlled-release. (1) | Actinomycetes (1) |
| Activator procaspase-3 (1) | active pharmaceutical ingredient (1) | Active site (1) |
| Activities of daily living (ADL) scale (1) | Acupuncture (1) | Acute appendicitis (1) |
| Acute generalized exanthematous pustulosis (1) | Acute Inflammation (1) | Acute inß ammation (1) |
| Acute Kidney Damage (1) | Acute poisoning (1) | Acute Side Effects (1) |
| Acute ST segment elevation myocardial infarction (1) | Acute toxicity (1) | acyclovir (2) |
| Adenanthera (1) | Adenosine A 2A antagonist (1) | Adherence (5) |
| Adherence. (1) | Adiantum venustum (1) | Adjuvant therapy (1) |
| ADME properties. (1) | ADR (2) | ADR management (1) |
| ADR monitoring centre (AMC). (1) | ADRs (2) | Adsorbent (1) |
| Adverse drug event (1) | adverse drug events (1) | Adverse drug reaction (10) |
| Adverse Drug Reaction (ADR) (1) | Adverse Drug Reaction and Antihypertensive medications. (1) | Adverse drug reaction. (1) |
| Adverse Drug Reactions (9) | Adverse drug reactions (ADRs) (1) | Adverse event (1) |
| Adverse event following immunization (AEFI) (1) | Adverse events (1) | Adverse reaction (1) |
| Aedes aegypti (2) | Aerobic exercise (1) | Aerosil (1) |
| affective ; assessment ; cognitive ; learning domains ; psychomotor (1) | Age (2) | Ageratum conyzoides L (1) |
| air pollution (1) | Airjet (1) | Albendazole (1) |
| Albino mice (1) | Albino wistar rats (1) | Alcohol (2) |
| alcoholic extract (1) | ALDEN (1) | Aldose reductase inhibitors (1) |
| allantoin (1) | Allergic rhinitis (1) | Allergy (4) |
| Alloxan (1) | Alloxan monohydrate (1) | Alocasia indica Schott (1) |
| Aloe vera (1) | Alpha mangostin (1) | Alpha-adrenoceptor (1) |
| alpha-delta-bungarotoxin-4 (1) | Alpinia speciosa (1) | Alprazolam (1) |
| Alteration of drug cost (1) | Altered Mental Status (AMS) (1) | alternative therapy (1) |
| Alzheimer's disease (1) | Alzheimers disease (1) | Alzheimer’s disease (1) |
| Amaranthus spinosus Linn (1) | Amber (1) | Ambroxol hydrochloride (1) |
| Amides (1) | Amikacin Sulfate (1) | Amino acids (1) |
| amino benzylated Mannich bases (1) | amivudine (1) | Amlodipine (2) |
| Amlodipine besylate (2) | Ammonium salts (1) | Amoora cucullata. (1) |
| amoxicillin (1) | Amoxicillin sodium (1) | Anabolic. (1) |
| Anaemia (2) | Analgesia (1) | analgesic (8) |
| Analgesic effect (1) | analgesic- anti-inß ammatory activity (1) | Analgesics (1) |
| Analysis in capsules (1) | Analysis of variance (1) | Anaphylactic shock (1) |
| Anaphylaxis. (1) | and TGF–β (1) | Andragogy (1) |
| Anemia (1) | Anethum graveolens (1) | Angiogenesis (1) |
| Angiogenic growth factors (1) | Angiotensin Converting Enzyme Inhibitors (1) | Animal model (1) |
| antepartum (1) | anthelmintic (1) | anthelmintic property (1) |
| Anthocyanin (1) | Anthracyclines (2) | Anti aging (1) |
| Anti hyperglycemic (1) | Anti inflammatory (1) | anti-anxiety activity (1) |
| Anti-asthmatic activity (1) | Anti-Cancer Activity (1) | Anti-diabetes mellitus. (1) |
| Anti-diabetic drugs (1) | Anti-epileptic drugs utilization (1) | Anti-HIV (1) |
| anti-hypertensive agent (1) | Anti-infective (2) | Anti-infective agents (1) |
| anti-inflammation (1) | anti-inflammatory (7) | Anti-inflammatory Activities of Total Leaf Extracts of Ficus sycomorus L. (Moraceae) used in Traditional Medicine in the Treatment of Sickle Cell Disease (1) |
| anti-inflammatory activity (2) | anti-inflammatory activity', (1) | anti-inflammatory agent (1) |
| anti-inß ammatory (3) | Anti-inß ammatory activity (1) | Anti-obesity (1) |
| Anti-oxidant (2) | Anti-parkinsonism activity (1) | anti-spasmodic drug (1) |
| Anti-tumor agent (1) | antiamnesic agents (1) | Antianxiety (1) |
| antibacterial (3) | antibacterial activity (4) | Antibacterial drugs (1) |
| Antibiotic (2) | antibiotic guidelines (1) | Antibiotic Resistance (2) |
| Antibiotics (5) | Antibiotics. (1) | Anticancer (5) |
| Anticancer activity (1) | Anticancer drugs (1) | Anticholinergic (1) |
| Anticoagulant (1) | Anticoagulant service (1) | anticonvulsant activity (1) |
| anticonvulsants (1) | Anticovulsant (1) | Antidepressants (1) |
| Antidesma bunius (2) | Antidiabetic (3) | Antidiabetic activity (2) |
| Antidiabetic agents (1) | antiepileptic agents (1) | Antiepileptic Drugs (3) |
| antifungal (1) | antifungal activity (1) | Antigen (1) |
| antigen protein (1) | Antiglycation (1) | Antihistaminic (2) |
| Antihyperglycemic (1) | Antihypertensive (1) | Antihypertensives (1) |
| Antiinflamatory (1) | Antimalarial (2) | Antimicrobial (4) |
| Antimicrobial activities (1) | Antimicrobial activity (6) | Antimicrobial agent (1) |
| Antimicrobial efficacy (1) | Antimicrobial resistance (1) | Antimicrobial resistance; Prescribing practice; Anti-infective agents; Antibacterials; Pharmacoepidemiology. (1) |
| Antimicrobial Stewardship (1) | Antimicrobials (4) | Antimosquito (1) |
| Antimycotic Activity (1) | antinociceptive (1) | Antioxidant (19) |
| Antioxidant ; carotenoid ; humans ; half-life ; status ; absorption . (1) | Antioxidant activity (6) | antioxidant effect (1) |
| Antioxidant properties (1) | Antioxidants (6) | Antipsychotics (1) |
| antipyretic (2) | Antiretroviral drugs (1) | Antiretroviral therapy (2) |
| Antispasmodic (1) | Antithrombotic (2) | Antithyroid drugs (1) |
| Antitubercular (1) | Antitubercular drugs. (1) | antiulcer (1) |
| Antivenom (1) | Antivenom reactions (1) | Antiviral (2) |
| antiviral activity (1) | Antiviral RNA (1) | Anxiety (2) |
| APAP (1) | APC (1) | Apoptosis (2) |
| Application (1) | Application to PK profile studies (1) | applications (1) |
| Appropriateness (1) | Aqueous extract (3) | AR Caps (1) |
| Arabic gum (1) | ARBs (1) | ARDS (1) |
| Area above the blood glucose levels-time curve. (1) | area of wound healing (1) | Areca nut (1) |
| Arginase (2) | Arginine (1) | Armodafinil (1) |
| ART (1) | Artemia salina (1) | Artemia salina. (1) |
| Artemisia (2) | Artemisia absinthium (1) | Artemisia macrocephala (1) |
| arterial hypertension (1) | Arteriovenous malformation (AVM) (1) | Arthritis (1) |
| ARV Drugs (1) | Ascorbic acid (3) | Asenapine (1) |
| asian developing nations (1) | Asiaticoside (1) | Asparagus racemosus root extract (1) |
| Aspergillus niger (2) | Aspergillus niger. (1) | Aspergillus terreus (1) |
| Aspirin (1) | Assay (2) | Asthma (4) |
| Asymptomatic neurocognitive impairment (1) | Ataxia (2) | ATC/DDD (3) |
| Atenolol (1) | Atherosclerosis (2) | Atherosclerotic Vascular Disease (1) |
| Atorvastatin (5) | Atorvastatin calcium (1) | Atorvastatin. (1) |
| ATP synthase inhibitor (1) | ATP- sensitive K+channel (1) | Atractylis flava Desf (1) |
| Atrial fibrillation (1) | Atropine (1) | Attitude (6) |
| Attitude and practice (1) | Attitude. (1) | Atypical antipsychotics (1) |
| Aucubin (1) | Authors (1) | Authorship issues (1) |
| Autism spectrum disorders (1) | Auto antibody (1) | Auto medication (1) |
| Autoimmune disorders (1) | Autoimmunity (1) | Averrhoa bilimbi (1) |
| Avicel (1) | Awareness (2) | Ayurveda (3) |
| Ayurvedic (1) | Azelaic acid (1) | Azilsartan medoxomil (1) |
| B cell epitope (1) | Bacoside A3 (1) | Bacteremia (4) |
| Bacterial isolates (1) | Bacteriological culture (1) | Bacteriostatic (1) |
| Bamboo betung (1) | Banana (1) | Bangladesh (2) |
| bark (1) | Barleria cristata (1) | Barriers (1) |
| Bauhinia racemosa (1) | Bauhinia variegata (2) | Bay-K-8644 (1) |
| Bayesian confidence propagation neural network (1) | BCG vaccine (1) | BCS-IV drug (1) |
| Beauty Salon Owner (1) | Beck Depression Inventory (1) | Beck Depression Inventory(BDI) (1) |
| Bedaquiline (1) | Belief (1) | Benchmarking (1) |
| Benzimidazole derivative (1) | benzimidazoles (2) | Benzodiazepines (1) |
| Benzothiazole analogues (1) | Berberis integerrima Bunge (1) | Beta-lactamic (1) |
| Bibliometrics (3) | Bioactive Metabolites (1) | Bioadhesive (1) |
| Bioanalytical method (3) | Bioanalytical method development (1) | Bioassay (1) |
| bioavailability (5) | Biodegradable (1) | Bioethics (1) |
| Biofilm (1) | Biohazard (1) | Biologics (1) |
| Biology (1) | Biomedical (1) | Bioprospecting. (1) |
| Biopsy Proven Acute Rejection (1) | Biosafety (1) | Biosafety Engineering Control (1) |
| Biotechnology (1) | Bitter (1) | Black tea extract (1) |
| BLAST (1) | Bleaching (1) | Bleeding time (1) |
| Bleomycin (1) | Blonanserin (1) | Blood brain barrier (1) |
| Blood glucose (1) | Blood pressure (3) | Body Mass Index (1) |
| Boerhaavia Diffusa (1) | Bone (1) | Book Review (1) |
| Borg scale (1) | botulinum toxin (1) | Box-Behnken (1) |
| Brahmi vati (1) | Brain (1) | Brand Drugs (1) |
| brand name drugs (1) | Branded medication (1) | Bratton-Marshall reagent (1) |
| Brazil (1) | Breast cancer (6) | Brewer’s yeast (1) |
| Brief COPE scale (1) | Brief medication questionnaire (1) | Brimonidine tartrate (1) |
| brine shrimp lethality bioassay (1) | Brine-shrimp lethality. (1) | Bromelain (1) |
| Bromeliaceae (1) | Bromocresol purple (1) | Bronchial Asthma (1) |
| Bryonia laciniosa (1) | Buccal (1) | Buccal Patches (1) |
| budget forecasting (1) | Bufadienolide (1) | Bullous eruption (1) |
| bungarotoxin (1) | Bungarus caeruleus (1) | Bungur (1) |
| Buni-berry extract (2) | Buoyant microspheres (1) | Burden Of Disease (1) |
| Business method (1) | Business model (1) | Butea monosperma (1) |
| C934 (1) | Ca2+ channels (1) | Cadmium chloride (1) |
| Caesalpinia decapetala (1) | Caesalpinia pulcherrima (1) | Caesalpinia pulcherrima (L.) Sw. stem bark (1) |
| Caesalpinia sappan (1) | CAGR (1) | Calcineurin inhibitor (1) |
| Calcium (1) | Calcium channel blocking (1) | calcium channel blocking activity (1) |
| Calcium oxalate (1) | Calcium silicate (1) | Calendula officinalis (1) |
| calendula oil (1) | CAM Assay (1) | Camelia sinensis extract (1) |
| Camellia sinensis (1) | Camptothecin (1) | Cancer (5) |
| Cancer Chemotherapy (2) | Cancer treatment (1) | Candida (1) |
| Candida albicans (3) | Candida albicans. (1) | Capacity (1) |
| Capsule (1) | capsules (1) | carbamazepin (1) |
| Carbamazepine (2) | carbohydrazide (1) | Carbomyl Linkage (1) |
| carbon tetrachloride (1) | carbonyl compounds (1) | Carbopol 940 (1) |
| Carcinoma. (1) | cardiac arrhythmias (1) | Cardiac remodeling (1) |
| Cardiology (1) | Cardioprotection (1) | Cardioprotective (1) |
| Cardiotoxicity (2) | Cardiovascular disease (1) | Cardiovascular drugs (1) |
| Carnauba wax (1) | carrageenan (2) | Caryocar coriaceum (1) |
| Case report (1) | Casein (1) | Casein Phosphopeptide-amorphous calcium Phosphate (1) |
| Catalase (1) | catalepsy (2) | Cation-pi (1) |
| CationicGuargum (1) | Causality assessment (2) | Causality scales (1) |
| CCKNOW - Crohn’s and Colitis Knowledge assessment questionnaire (1) | CD150 (1) | CD244.2 (1) |
| CD48 (1) | Cefixime (1) | Cefotaxime (1) |
| ceftriaxone and co-amoxiclav (1) | Cefuroxime (1) | Cefuroxime Axetil (1) |
| cell viability Glycyrrhiza glabra (1) | Cellulase (1) | Cellulite (1) |
| Cellulitis (1) | Cellulose (2) | Cemented (1) |
| Cementless (1) | CEN (1) | Centella asiatica (3) |
| Central composite design (4) | Central post-stroke pain (1) | Cephalexin (2) |
| Cerebrovascular Accident (1) | Cervical dentine hypersensitivity (1) | CFFF (1) |
| chalcone (1) | chalcones (1) | Challenges (1) |
| Characterization (4) | Chebulinic acid (2) | Chemical stability (1) |
| Chemiluminescence (1) | Chemomechanical removal (1) | Chemometrics (2) |
| Chemotaxis (1) | Chemotherapy (5) | Chewing gum (1) |
| Child Care (1) | Children (2) | Children Dentistry (1) |
| Chitin (1) | Chitosan (6) | Chitosan Acetate. (1) |
| chitosan microspheres (1) | Chitosan nanoparticle (1) | Chitosan-g-HPβCD (1) |
| Chlamydomonas reinhardtii (1) | Chloramphenicol (1) | Chlorhexidine (2) |
| Chlorohexidine (1) | cholesterol (1) | Cholesterol HDL (1) |
| Cholinesterase inhibitors (1) | Chromotropic acid reagent (1) | Chronic hepatitis B (2) |
| Chronic kidney disease (1) | Chronic Obstructive Pulmonary Disease (COPD) and Elderly Patient. (1) | Chrysophyllum cainito L. leaves (1) |
| Cicer arietinum (1) | Cigarette smoke (1) | Cilostazol (1) |
| Cinnamaldehyde (1) | Cinnamic acid derivatives (1) | Cinnamomum cassia (1) |
| Ciprofloxacin (1) | Citronella (1) | Citrus hystrix (1) |
| Citrus limon (2) | CKD (1) | CKMB. (1) |
| Claims (1) | Clarithromycin (1) | Classification (1) |
| Clastogenicity (1) | Cleistanthin A (2) | cleistanthin B (2) |
| Cleistanthus Collinus (1) | Clinical attachment (1) | Clinical attachment level (1) |
| Clinical efficacy (1) | Clinical equivalence (1) | Clinical manifestation (1) |
| Clinical Pharmacist (1) | Clinical pharmacist care (1) | Clinical pharmacology (1) |
| Clinical Pharmacy Services (1) | Clinical research (1) | Clinical trial (1) |
| Clinical trials (1) | Clinicians (1) | clonidine (2) |
| Clopidogrel (1) | Closed melt (1) | Clove (1) |
| cloxacillin (1) | Cluster analysis (1) | CME (1) |
| Co-crystal (1) | Co-Morbidity (1) | Co-morbidity. Correspondence (1) |
| co-precipitation method (1) | Co-surfactant (1) | Cochlopermum tinctorium (1) |
| coding system (1) | Cognition (2) | Cogrinding (1) |
| Colloidal carriers (1) | Colloidal silicone dioxide (1) | Colon targeted delivery (1) |
| Colon targeted drug delivery. (1) | Colon targeting (1) | Colonic delivery (1) |
| colorimetric assay (1) | Combination tablet (1) | Combination Therapy (1) |
| Combinatorial effect (1) | Comet assay (1) | common cold (1) |
| common cold and cough (1) | Common warts (1) | Community Pharmacies (1) |
| Community pharmacist (1) | Community pharmacists Pharmaceutical Care service (1) | Community pharmacy (1) |
| Comorbidity (1) | comparative molecular similarity indices (1) | comparative molecular Þ eld analysis (1) |
| compensation (1) | Complementary and alternative medicine (2) | complementary and alternative medicines (1) |
| Complementary and alternative therapy (1) | complete epithelization (1) | Compliance (1) |
| compound 48/80 (2) | compritol 888 ATO (1) | Computer (1) |
| Computer literacy (1) | computer-aided instructions (1) | Computer-aided learning (1) |
| Computerized screening systems (1) | CoMSIA (1) | Constipation (1) |
| Consumer (1) | Consumer perception (1) | Consumption (1) |
| Content validation (1) | content validity (1) | continuing education (1) |
| Contract research (1) | Contract research organizations (1) | Controlled release (4) |
| convolution (1) | convulsions (1) | cooperative practice (1) |
| COPD (2) | Coprocessed excipient (1) | Cordia obliqua (1) |
| Corneal opacities (1) | Coronally advanced flap (1) | Correlation (2) |
| Corticosteroid (2) | Corticosteroids (1) | Cosmetic (2) |
| Cost avoidance (1) | Cost of illness (2) | Cost saving (1) |
| Cost-effectiveness analysis (1) | Cost. (1) | Costing Analysis. (1) |
| Cotton dust (1) | Cotton oil (1) | cotton pellet (1) |
| Cough (1) | Cough medicine (1) | cough. (1) |
| Counterfeit Pharmaceutical Products (1) | Cramer’s Matrix method (1) | CRC (1) |
| Cream (1) | creatinine (1) | Critical Care Unit (CCU) (1) |
| Critical Thinking (1) | cromolyn sodium (1) | Cronbach’s alpha (1) |
| Croscarmellose sodium (CCS) (1) | Crospovidone (1) | Crospovidone (CP) (1) |
| Cross carmellose sodium (1) | cross-linking agents (1) | Crossandra (1) |
| Croton zehntneri (2) | Crystallinity (2) | CTCAE (1) |
| CTEPH (1) | Cucumis metuliferus (1) | Cucumis sativus (1) |
| CUMIN. (1) | Cuminosides (1) | Curcuma longa (1) |
| Curcumin (3) | current indian scenario of drug interactions (1) | curriculum development (1) |
| Cutaneous Adverse Drug Reactions (CADRs) (1) | Cutaneous reaction (1) | CXCR4 (1) |
| Cyclodextrin (1) | Cyclooxygenase (1) | cyclophosphamide (1) |
| Cymbopogon citratus (1) | Cynodon dactylon (2) | CYP genes ; South Indian population ; polymorphisms (1) |
| Cyst (1) | Cytochrome P 2C9 (1) | Cytosine (CYS) (1) |
| Cytotoxic (1) | Cytotoxic activity. (1) | Cytotoxic agents (1) |
| Cytotoxicity (3) | CZE (1) | D&C (1) |
| D-optimal design (1) | Daily Defined Dose (1) | Dapsone (1) |
| Data mining algorithms (1) | DDX3 (1) | Death Receptors (1) |
| Decision making (1) | Deep vein thrombosis (1) | deferasirox (1) |
| deferiprone (1) | Deficiency (1) | Degradation (1) |
| Degradation studies (1) | Dehydrozingerone (1) | Delignification (1) |
| Delirium (2) | democratic government (1) | Dengue high fever (1) |
| Dental caries (3) | Dental Caries. (1) | Dental implants (1) |
| dental management (1) | Dental prosthesis. (1) | Dental Restoration (1) |
| Dental Students (1) | dentistry. (1) | Dentists (1) |
| Deodorants (1) | Dependence (1) | Depigmentant (1) |
| Depok Primary Health Care (1) | Deprescribing (1) | Depression (3) |
| Dermatology life Quality Index (1) | Design of experiments. (1) | desirability function (1) |
| Desirability index. (1) | Desmodium gangeticum (1) | Detorsion (1) |
| Deuterium (1) | device safety (1) | dexamethasone (2) |
| Dexibuprofen (1) | Dextrin (1) | Diabetes (6) |
| diabetes and diabetic vascular complications (1) | Diabetes mellitus (11) | diabetes mellitus, (1) |
| Diabetes Type-II (1) | Diabetes, glucose (1) | diabetic dyslipidemia (1) |
| Diabetic nephropathy (1) | Diabetic retinopathy (1) | Diabetic Wound (1) |
| Diacerein (1) | DiaKure (1) | diclofenac (1) |
| Diclofenac SLN (1) | Diclofenac sodium (1) | Dicots (1) |
| Dicyclomine (1) | Dietary Supplements (1) | differential scanning calorimetry (1) |
| diffuse transmittance (1) | Dillenia indica (2) | Dilleniaceae (1) |
| Diltiazem Efficacy (1) | Diltiazem hydrochloride (2) | Dimethylpyrimidin-derivatives (1) |
| Dip coating (1) | Diplotropis ferruginea (1) | direct compression (3) |
| Direct to consumer advertising (1) | Directly observed treatment short-course (1) | Discharge against medical advice (DAMA) (1) |
| discharge orders (1) | DISCLE (1) | Discrepancies (1) |
| Discriminant analysis (1) | Disease (1) | Disease free survival (1) |
| disintegration (1) | disintegration time (1) | Disproportionality Analysis (1) |
| Dissolution (5) | dissolution enhancement (1) | Dissolution rate (1) |
| Diuretic (1) | Diuretic activity (2) | DMAIC (1) |
| DMH (1) | DNA barcoding (1) | DNA damage (1) |
| DNA fragmentation (1) | docking (3) | docking. (1) |
| Doctor (1) | Documentation (1) | Documentation and records (1) |
| Donepezil hydrochloride (1) | Dopamine (1) | Dosage formulation (1) |
| Dosage regimen (1) | Dose-dependent (1) | DOTS plus (1) |
| Doxorubicin (2) | Doxorubicin; FRAP assay (1) | Doxycycline (1) |
| DPP-IV (1) | DPPH Assay (1) | DPPH scavenging (1) |
| DRcaps (1) | DREEM. (1) | Dried blood spot. (1) |
| Dried blood spot; pharmacokinetic; validation; hydrochlorothiazide (1) | droplet size (1) | Drug (2) |
| Drug delivery denture (1) | Drug detailing (1) | drug disposal (1) |
| Drug drug interactions (1) | Drug Hypersensitivity (1) | Drug induced nephrotoxicity (1) |
| Drug Information and Literature Evaluation (1) | drug interaction (2) | Drug interaction (DI) (1) |
| drug interaction management (1) | Drug Interaction probability scale (1) | drug interactions (2) |
| Drug prescriptions (1) | Drug product (1) | Drug Related Problems (4) |
| Drug related side effects (1) | drug release (1) | Drug Resistance (2) |
| Drug risk ratio (1) | Drug safety (2) | Drug Safety. (1) |
| Drug therapy (1) | Drug utilization (3) | drug utilization study (1) |
| Drug utilization. (1) | drug-drug interactions (4) | Drug-related problem (2) |
| Drug-SLS tablets. (1) | Drugedrug interaction (1) | Drugs (2) |
| Drugs and Cosmetics rules (1) | drug–drug gliclazide (1) | Drug–drug interaction (1) |
| Dry extract cinnamon (1) | DSPC (1) | Dual Therapy (1) |
| dual-target-directed drugs (1) | Dunaliella salina (1) | Dynamic (1) |
| Dyslipidemias (1) | Dysphagia (1) | E-pharmacy websites (1) |
| e-prescribing (1) | E. coli (1) | E.crispa (1) |
| Early-Related Complications (1) | EC50 values (1) | Economic (1) |
| Economic burden (1) | Edaravone (1) | Eddy’s hot plate method. (1) |
| edema (1) | Editorial (24) | Education (2) |
| Educational excellence (1) | efavirenz (2) | Efficacy. (1) |
| EGCG (1) | Egfr (1) | egg albumin microspheres (1) |
| Elderly (1) | Elderly Patients (1) | Electrochemical (1) |
| electrolyte release (1) | electrolytes (1) | Electron beam radiation (1) |
| Electronic prescribing (1) | Electronic prescription (1) | Electroporation (1) |
| Elevated plus maze (1) | elevated plus maze model (1) | Elisa (1) |
| Emblica offi cinalis (1) | Emergency contraception (1) | Emodin (1) |
| Emotional (1) | Emulgel (1) | Emulsification and Solvent Evaporation (1) |
| emulsion solvent diffusion method (1) | emulsion solvent diffusion-evaporation technique (1) | Encholirium spectabile (1) |
| Endocrine disruptor (1) | Endophytes (1) | Endothelial cells (1) |
| endothelial Nitric Oxide Synthase (1) | Endothelial progenitor cells (1) | Endothelium (1) |
| Endothelium. (1) | Enicostemma littorale (1) | Entire plant (1) |
| Entrapment afficiency (1) | entrapment efficiency (2) | Envenoming (1) |
| Environmental Factors (1) | Enzymatic hydrolysis (1) | Enzyme kinetics (2) |
| eosinophil (1) | Epigallocatechin Gallate (2) | Epigallocatechin gallate (EGCG) (1) |
| Epigenetics (1) | epilepsy (4) | Epithelial ovarian cancer (1) |
| EQ5D (2) | erbal drugs (1) | erice declaration (1) |
| Erythema (1) | Erythrina indica (1) | Erythrina variegata (1) |
| erythropoietin (1) | Escherichia coli (1) | Escitalopram oxalate (1) |
| esomeprazole (1) | Essential hypertension (2) | Essential medicine (1) |
| essential medicines (1) | essential oil (4) | essential oil composition (1) |
| Essential principles (1) | Esthetics Dental (1) | Estimated Glomerular Filtration Rate (1) |
| Estrogen receptor alpha (1) | Ethanol (1) | Ethanol extract (1) |
| ethanolic extracts (1) | Ethiopia (2) | ethnicity (2) |
| Ethnomedicine (1) | Ethosomes (1) | Ethyl - 4- acetamido phenoxy acetate (1) |
| Ethyl acetate (1) | Ethyl acetate fraction (1) | ethyl cellulose (2) |
| ethylcellulose (3) | ethylene glycol (2) | Eucalyptus (1) |
| Eucalyptus hybrid (1) | Eucalyptus oil (2) | eudragit (1) |
| Eudragit RL 100 (1) | eudragit S100 (2) | Eudragit-L100 (1) |
| Eudragit® S100 (1) | Eugenol (1) | Euphorbia hirta leaves (1) |
| Eurycoma Longifolia Jack (1) | Ex vivo tissue entrapment (1) | ex-vivo performance (1) |
| Ex-vivo permeation (1) | Ex-vivo study (1) | Excision wound model (1) |
| Expectoration (1) | experiences (1) | Experiential learning (1) |
| Experimental ischemic stroke (1) | experimental study (1) | Expired medicines (1) |
| Exports (1) | Expression profile (1) | Extract (1) |
| Extrapyramidal side-effects (1) | extrinsic stains (1) | extrusion (1) |
| Eye lens (1) | Ezetimibe (2) | Fabaceae (2) |
| Factor analysis (1) | factorial design (5) | Factors associated with medication non-adherence (1) |
| Falcipain-2 (1) | Family Planning Services (1) | Family satisfaction (1) |
| family therapy (1) | famotidine (2) | fast disintegrating tablet (1) |
| Fast Disintegrating Tablets. (1) | Fast dissolving film (1) | Fast dissolving films (1) |
| Fast dissolving tablets (1) | Fasting serum insulin level (1) | Fat (1) |
| Fatty acid profile (1) | FC reagent (1) | FDA AERS Database (1) |
| FDA Approval (1) | Fenugreek (1) | Ferritin (1) |
| Ferrous sulfate (1) | Fialuridine', (1) | Ficus bengalensis (1) |
| Ficus bengalensis (Moraceae) (1) | Ficus racemosa (1) | film (1) |
| film hydration (1) | First permanent molars (1) | Fixed drug eruption (1) |
| Flavonoid (3) | Flavonoid Compounds (1) | Flavonoid fraction (1) |
| flavonoids (2) | Flavoxate HCl (1) | FlK-1 (1) |
| Floating beads (1) | floating controlled drug-delivery system (1) | Floating drug delivery system (1) |
| floating lag time (1) | fluoroquinoes (1) | Fluoxetine (1) |
| Flupritine maleate (1) | flurbiprofen (1) | Flux (1) |
| FMCG (1) | folkloric use (1) | Food drug and cosmetic act (1) |
| Forced degradation (3) | Forced degradation studies (1) | forced swim test (1) |
| Formulary (1) | Formulary. (1) | Formulation (3) |
| Formulation and development (1) | Fourier transform infra red spectroscopic (1) | FPG (1) |
| FPGEE (1) | Fraction (1) | Franz Diffusion Cell (3) |
| free radical scavenger (1) | Free radicals. (1) | Freeze-drying (1) |
| Freund’s complete adjuvant (1) | Fructo-Oligosaccharide (FOS) (1) | Frusemide (1) |
| Frusemide-induced complications (1) | FTIR (4) | Fumes (1) |
| furosemide (1) | G6PD deficiency (1) | Galacto-Oligosaccharide (GOS) (1) |
| Galic Acid (1) | gallic acid (4) | Gamma irradiation (1) |
| Gangrenous (1) | Ganoderma lucidum (1) | Gap Junctions; Hypersynchronization; Pentylenetetrazole; Maximal Electroshock (1) |
| Garcinia daedalanthera extract (1) | Garcinia imberti bourd (1) | Garcinia indica (1) |
| Garcinia latissima (1) | gaseous contact (1) | gastric treatment (1) |
| Gastric ulcer (1) | Gastro-retentive drug delivery system (1) | gastroprotection (2) |
| gastroretentive (1) | gastroretentive drug delivery system (1) | Gatot Soebroto hospital. (1) |
| GC-MS (1) | GC-MS analysis (2) | GC-MS. (1) |
| GDP (1) | Gelatin (1) | Gelling Capacity. (1) |
| Gels (1) | Gemcitabine HCl (GCH) (1) | gemfibrozil (1) |
| Gender (1) | Gender and HIV. (1) | Gene expression (1) |
| Gene expressions (1) | Gene silencing (1) | General medicine (1) |
| Generic (2) | generic drugs (2) | Generic medicines (2) |
| Generic name. (1) | Generic substitution (1) | Generics (1) |
| Genetic polymorphisms (1) | genetic Signature (1) | Genotoxin (1) |
| Genotype frequency (1) | Gentamicin (4) | gentamicin sulfate (2) |
| Geriatrics (3) | GFAP (1) | Gibb’s reagent (1) |
| Ginger (1) | Gingival hyperplasia (1) | Gingival hypertrophy (1) |
| gingival pocket (1) | Gingival recession (1) | Gingival thickness (1) |
| Gladiolus segetum (1) | glibenclamide (4) | gliclazide (2) |
| Glimepiride (2) | glimepride (1) | Glipizide (3) |
| glitazars (1) | Global education (1) | Glomerulonephritis (1) |
| Glucagon (1) | Glucocorticoids (1) | Glucose (1) |
| glucose tolerance test (1) | glutathione (1) | Glycerin (1) |
| Glycerine (1) | Glycine max (1) | Glycosylated hemoglobin (HbA1c) (1) |
| Glycosylated hemoglobin A1c (1) | Gnetum gnemon (2) | Goal orientation (1) |
| Goldenhar syndrome (1) | good manufacturing practices (1) | Gotu kola leaves extract (1) |
| GPx (1) | Graft Survival (1) | Grafting (1) |
| Gram negative (1) | Gram positive (1) | Grape seed extract (1) |
| Grape seed oil (1) | Grapes seed extract (1) | Gravimetry (1) |
| Grazing angle X-ray diffraction (1) | Green tea (1) | Green Tea Leaves Extract (2) |
| Griseofulvin (1) | GSH (2) | guanyl cyclase stimulator (1) |
| Guest Editorial (1) | Guidelines (1) | Gulf cooperation council (1) |
| Gum and fat fractions (1) | Gum arab (1) | Gymnema Sylvestre (2) |
| GYTS (1) | H+ (1) | H-460 (1) |
| H2 Receptor Antagonist (1) | H2O2 (1) | HAART (1) |
| Haematological (1) | Haemoglobin (1) | Haemolysis (1) |
| Haemolytic ratio. (1) | Hair dye. (1) | Hair Growth Activity (1) |
| Hair Tonic (1) | Hajj (1) | haloperidol (1) |
| Hand and Foot Syndrome (1) | hardness (1) | Haritaki (2) |
| harmacotherapy-based problems (1) | Harmonization (2) | Hazardous drugs (1) |
| HbA1C (2) | HBV (1) | HCT: Hydrocholrothiazide. (1) |
| HDAC4 (1) | HDAC7 (1) | head twitch (1) |
| Health benefits (1) | Health care profession (1) | health care professionals (1) |
| health care students (1) | Health care. (1) | Health Effect (1) |
| Health Hazard (1) | Health informatics (1) | Health Information Technology (1) |
| Health problems (1) | Health Services Accessibility (1) | Healthcare (4) |
| healthcare communication (1) | Healthcare Delivery (1) | healthcare expenditure (1) |
| Healthcare Professionals (1) | healthcare providers (1) | Healthy volunteers (1) |
| heart failure (2) | Hematological parameters (1) | hematological toxicity (1) |
| Hematology (2) | Hematoma (1) | Hematopoietic progenitors (1) |
| Hemodialysis (1) | hepatic impairment (1) | Hepatitis (1) |
| Hepatitis B (1) | Hepatitis B virus core protein (1) | Hepatocellular (1) |
| Hepatocurative (1) | hepatoprotective (2) | hepatoprotective activity (3) |
| Hepatotoxicity (1) | HER1 (1) | HER2 (1) |
| HER3 (1) | HER4 (1) | Herbal active ingredients (1) |
| Herbal drugs (1) | Herbal medications (1) | Herbal medicine (2) |
| herbal medicines (1) | Herbal therapy (1) | Herbaldb (1) |
| HET-CAM (1) | Heterocyclic compound (1) | Heterotopic Pregnancy (1) |
| Hex (1) | Hexane (1) | Hibiscus cannabinus Linn. (1) |
| Hibiscus rosa. (1) | High fat diet (3) | High Fat Diet Model (1) |
| High impact resin (1) | high performance liquid chromatography (1) | high performance thin layer chromatography (1) |
| High-density lipoprotein cholesterol (1) | High-fat diet (1) | high-performance liquid chromatography (2) |
| High-throughput screening (1) | Higher education (1) | highly active antiretroviral therapy (1) |
| Highly Cited Papers (1) | Himatanthus drasticus (1) | Hip Arthroplasty (1) |
| Hirsutism (2) | Histocompatibility. (1) | Histological studies. (1) |
| Histopathological studies (1) | Histopathology (2) | HIV (1) |
| HIV associated dementia. (1) | HIV-1 RT (1) | HIV-associated neurocognitive disorder (1) |
| HIV/AIDS Patients (1) | HL-60 and K-562 (1) | HLA (1) |
| HMG-CoA Reductase (1) | homology modeling (1) | Honey (1) |
| Honeycomb (1) | Hordeum vulgare (1) | Hordeum vulgare hull (1) |
| Hospital pharmacy (2) | hospitalized children (1) | hospitalized patients (1) |
| Hospitals (1) | host (1) | Host-guest interactions (1) |
| hot plate (1) | HP-ß Cyclodextrin complexes (1) | HPLC (8) |
| HPLC (High Performance Liquid Chromatography) Ornidazole (1) | HPLC method validation (1) | HPLC. (1) |
| HPMC (1) | HPMC capsules (1) | HPMC K100M (1) |
| HPMC K4M (1) | HPTLC (7) | HQLQ (2) |
| HRQoL (3) | HSV-1 (1) | Human breast cancer cells (1) |
| Human breast cancer MCF -7 cells (1) | human immunodeficiency virus (3) | human immunodeÞ ciency virus (1) |
| Human Papillomavirus (1) | Human plasma (2) | human plasma level (1) |
| Human plasma; Liquid chromatography–tandem mass spectrometry (LC–MS/MS); Method validation; Pharmacokinetics (1) | Humanitarian device exemption. (1) | Hydnocarpus Pentandra (1) |
| Hydralazine hydrochloride (1) | Hydroalcoholic (1) | hydrochlorothiazide (1) |
| Hydrochlorthiazide (1) | hydrogel (2) | Hydrogels (1) |
| hydrogen sulfide (1) | hydrogenated castor oil (1) | Hydrophilic drugs (1) |
| Hydrophillic sealants (1) | Hydrophobic sealants (1) | hydroxy propyl methyl cellulose (1) |
| Hydroxyl radical (1) | hydroxypropyl cellulose (1) | hydroxypropyl methyl cellulose (2) |
| Hydroxypropyl methylcellulose (1) | Hydroxypropyl methylcellulose E15 (1) | Hydroxypropyl-β- cyclodextrin (1) |
| Hydroxypropylmethyl cellulose (1) | Hydroxypropylmethylcellulose (1) | Hyperactive orofacial musculature (1) |
| Hypercholesterolemia (1) | Hypercholestremia (1) | Hyperglycemia (1) |
| Hyperglycemic (3) | Hyperglycemic mice (1) | Hyperhomocystienemia (1) |
| Hyperlipoprotienemia(a) (1) | hyperoxaluria (1) | Hypersensitivity (1) |
| hypertension (5) | Hypertension( HTN) (1) | Hypertensive’s (1) |
| Hyperthyroidism (1) | hypertriglyceridemia (2) | Hypertrophy (1) |
| Hyperzincuria (1) | Hyphenated system (1) | hypoglycemic (1) |
| Hypoglycemic activity (1) | hypolipidemic (1) | Hypothyroidism (1) |
| Hypozincaemia (1) | IBD (1) | IBD - Inflammatory Bowel Disease (1) |
| IC50 (2) | ICH (2) | ICH guidelines (2) |
| ICP22 (US1) gene (1) | IL-17 (1) | IL-6 (2) |
| IL-MAE (2) | Illiterate (1) | Iloperidone (1) |
| image analysis (1) | imidazole (1) | Immune response (1) |
| Immune suppression (1) | immunocytochemistry (1) | Immunoinformatics (1) |
| Immunological response (1) | Immunomodulatory (1) | Immunomodulatory effect (1) |
| Impacted (4) | Improving (1) | Impurity (1) |
| In silico (2) | in situ gelation (1) | in vitro (4) |
| In vitro kinetics (1) | In vitro penetration lotion (1) | In vitro penetration test (1) |
| In vitro Penetration Test. (1) | In vitro release (1) | In vitro–In vivo (1) |
| in vivo (1) | In vivo kinetics (1) | In-patien (1) |
| in-vitro dissolution study (1) | In-vitro skin permeation (1) | Inclusion complex (1) |
| inclusion complexes (2) | indexed cost (1) | India (8) |
| India. (1) | Indian context (1) | Indian Traditional medicine (1) |
| Indion 234 (2) | Indion resin (1) | indomethacin (2) |
| Indonesia (1) | Indonesian Herbal Database. (1) | Indonesian National Health Insurance (1) |
| Industry (2) | Inequality (1) | infarct size (1) |
| infective endocarditis (1) | infertility (1) | Infit and outfit indices (1) |
| inflammation (3) | inflammatory bowel disease (2) | Information need (1) |
| Information system (1) | Information Technology Officers (1) | Information tool (1) |
| Inhibitor MDM2 (1) | Inhibitory activity (1) | innovation ecosystems (1) |
| inorganic salts. (1) | INR (1) | inß ammation (2) |
| inß ammatory bowel diseases (1) | Insilico anticancer screening (1) | insulin (5) |
| Insulin receptor (1) | Insulin regimen (1) | insulin resistance (1) |
| Insulin resistance. (1) | insulin use in primary care (1) | Insulinophobia (1) |
| Integrase inhibitor (1) | Integrated Courses (1) | integrated economic analysis (1) |
| Intellectual Property l (1) | Intellectual property rights (1) | intelligent tutoring (1) |
| Intensive care unit (1) | Intensive Care Unit (ICU) (1) | Intensive Monitoring (1) |
| interaction (2) | interferon (1) | interleukins (1) |
| International Collaboration (1) | International HIV dementia scale (IHDS) (1) | international organization (1) |
| international organizations (1) | international trade (1) | Internet (1) |
| Internet pharmacy (1) | interpretation (1) | Interventional tool (1) |
| Interventions (1) | Intracanal medicament (1) | intraocular presuure (1) |
| Intrauterine Pregnancy (1) | Intravenous (4) | inventory index (1) |
| inventory management (3) | investigators (1) | Invited Article (2) |
| ion pair complex (1) | Ionic gelation (1) | Ionic liquid (3) |
| Ionic liquid- based microwave-assisted extraction (1) | ionic liquid-based microwave-assisted extraction (1) | ionotropic gelation (1) |
| iontophoresis (2) | Iraq (1) | Iridoid glycoside (1) |
| iron chelation therapy (1) | Irrigation (1) | Irvingia gabonensis (1) |
| isatin (3) | ischemia (1) | ischemia-reperfusion injury (1) |
| Ischemic (1) | ischemic heart disease (1) | ISO (1) |
| isoniazid (2) | isonicotinohydrazide (1) | Isoprinosine (1) |
| Isopropyl myristate (1) | isoproterenol (1) | isoxazoline (1) |
| itopride HCl (1) | JNC 8 Guidelines. (1) | Journal (1) |
| Jurkat (1) | K+-ATPase β subunit (1) | K+ATP channel (1) |
| K-CAPS (1) | K562 (1) | Kaffir lime (1) |
| Kajjali (1) | Kalanchoe Pinnata (1) | KAP (1) |
| KAP study (1) | Kappa. (1) | Karachi (2) |
| Kathakakhadiradi kashyam (1) | Kati chakrasana (1) | Kernel powder (1) |
| Ketoprofen (1) | Ketorolac (1) | Ketorolac salt (1) |
| Key words: 5-FU (1) | Key words: Esomeprazole (1) | kidney (2) |
| kinetic drug release (1) | Kinetic Modelling (1) | KMnO4 (1) |
| kneading method (1) | kneading technique (1) | knowledge (10) |
| Kumar’s score (1) | L-arginine (1) | L-Thyroxine (1) |
| L. acidophilus (1) | labeling (1) | Laboratory findings. (1) |
| Lactobacilli (2) | Lactobacillus (1) | Lag period (1) |
| Lagenaria siceraria (1) | Lantana camara (1) | Lantana montevidensis (1) |
| Larvacidal (1) | Laurence-Moon-Bardet-Biedl Syndrome (1) | Lawsone methyl ether (1) |
| LC-MS (2) | LC/MS/MS (1) | LC50 (1) |
| LCMS/MS (1) | LC–MS/MS (1) | LDL-C (1) |
| Leaf (1) | Learning process (1) | leaves (4) |
| Leftover medicines, (1) | Leg Length (1) | Leptin (1) |
| Letter to Editor (4) | Letter to the Editor (3) | Letters to the Editor (6) |
| Leucaena leucocephala (1) | Leucas lavandulaefolia (1) | Levocetirizine (1) |
| Lexicomp (1) | Lichen planus (1) | Licofelone (1) |
| Ligand-based drug design (1) | Lightening (1) | Limb Length (1) |
| Limbs (1) | lime fruit (1) | Linezolid (1) |
| Linoleic acid (1) | lipid matrix (1) | lipid metabolism (2) |
| lipid microspheres (1) | Lipid nanocrystals (1) | Lipid peroxidation (3) |
| lipid peroxides (1) | lipid profile (1) | Lipid profile membrane bound enzymes (1) |
| lipids (1) | lipoic acid (1) | liposome (1) |
| Lippia (1) | lithium toxicity (1) | Live-well™ (1) |
| liver function (2) | Liver necrosis (1) | Liver tonic (1) |
| Liver Transplantation (1) | Local drug delivery (1) | locomotor activity (1) |
| Low-density lipoprotein cholesterol (1) | Lozenges (1) | Luffa echinata (1) |
| Luminesce (1) | Lung (1) | Lung cancer (3) |
| Lupenoic acid (1) | Lupus (1) | Lycatab C (1) |
| Lympadenopathy (1) | lymphadenitis (1) | Lysozyme (1) |
| M. tuberculosis H37Rv (1) | Maceration (1) | Macromicroscopy study (1) |
| Macrophage cell line (1) | Mahkoside A (1) | Major Contributed Organizations (1) |
| Malaysia (5) | Malaysia. (1) | Malaysian. (1) |
| malondialdehyde (2) | Maltodextrin (2) | Mammary carcinoma (1) |
| Mandibular hypoplasia (1) | Mangiferin (1) | Mangosteen Peels (1) |
| manidipine dihydrochloride (1) | Mannich base (1) | Mannich Bases (1) |
| Marine fungi compounds (1) | Mast cell (1) | Maternal Care. (1) |
| matrix (1) | Matrix Tablet (1) | matrix tablets (3) |
| MCF-7 (1) | MDA (2) | MDR-TB (2) |
| mean age (1) | Mechanism (1) | mechanisms (1) |
| Meclizine HCl (1) | Medical (1) | medical costs (1) |
| Medical device (1) | Medical device recalls (1) | medical errors (1) |
| Medical informatics (1) | Medical Inpatients (1) | Medical practitioner (1) |
| Medical Representative (1) | Medical sales representative (1) | Medical students (2) |
| medication adherence (5) | medication adherence behaviour (1) | medication error (2) |
| Medication errors (1) | Medication non-adherence (1) | Medication reconciliation (1) |
| Medication regimen complexity (1) | medication safety (1) | medication-/drug-related problem (MRP/DRP) (1) |
| Medicinal plants (3) | Medicine (2) | Medicine disposal (1) |
| medicine-use practices (1) | Medicines storage (1) | Medicines wastage (1) |
| Melanesia (1) | Melastoma malabathricum (1) | Melinjo (2) |
| Meloxicam (1) | Memory (1) | Memory and learning. (1) |
| Men (1) | Menaquinone-4 (2) | Menstrual cycle (1) |
| Mental health (1) | Mental health services. (1) | Mentha arvensis (1) |
| mesalamine (1) | Metabolic ratio (1) | Metabolic syndrome (1) |
| Metabolism (1) | Metabolite profiling (1) | Metabomics (1) |
| metagenomic (1) | metformin (7) | metformin hydrochloride (1) |
| Methanol (1) | methanolic extract (1) | methocel (1) |
| method development (2) | method validation (3) | Methotrexate (1) |
| methyl orange (1) | methyl-b cyclodextrin (1) | metoprolol tartarate (1) |
| MetS (1) | Mevalonate (1) | Micro emulsion (2) |
| Micro particles. (1) | Micro-emulsion (1) | microbial contamination (1) |
| Microbiological (1) | Microbroth dilution (1) | Microcapsules (1) |
| microcrystalline cellulose (5) | microdilution (1) | Microdosing (1) |
| Microencapsules (1) | microneedles (1) | Micronucleus assay (1) |
| microparticles (1) | microsphere (1) | Microsphere Phytosome (1) |
| microspheres (6) | microtriches (1) | Microwave assisted extraction (1) |
| Microwave-Assisted Extraction (2) | miglitol (1) | Migraine (2) |
| migraine management, (1) | Mild neurocognitive disorder (1) | Milk (1) |
| Milnacipran (1) | Mimosa pudica (1) | Mineral trioxide aggregate (1) |
| minimal inhibitory dose (1) | Minimum Inhibitory Concentration (MIC) (1) | mismatches (1) |
| mitochondria (1) | Mix mode (1) | MMAS-8 - Modified Morisky Adherence Scale-8 (1) |
| Modeling (1) | modern medicine (1) | modified melt dispersion technique (1) |
| Modified Starches (1) | MODY (1) | Mol inspiration (1) |
| Molecular characterization (1) | Molecular docking (10) | molecular docking and anti cancer activity. (1) |
| Molecular Docking. (1) | Molecular Dynamic (1) | Molecular dynamics (3) |
| Molecular Dynamics Simulations (1) | Molecular Imprinted Polymer (1) | Molecular mimicry (1) |
| monoamine oxidase B (1) | Monocots (1) | Monophyletic (1) |
| montelukast (2) | montelukast sodium (1) | Montelukast, (1) |
| moraceae (1) | Morbidity (1) | Morin and validation (1) |
| Moringa oleifera (2) | Moringa oleifera. (1) | Morisky medication adherence questionnaire (1) |
| Mortality (3) | Morus alba (2) | Mosquito repellent (1) |
| Mouth Dissolving Tablets (1) | mouth-dissolving film, (1) | MPO activity (1) |
| MPTP (1) | MTT Assay (2) | MTT method (1) |
| MUC2 (1) | MUC6 (1) | Mucoadhesive (1) |
| Mucoadhesive agent (1) | mucoadhesive formulation (1) | Mucoadhesive Oral In situ gel (1) |
| mucoadhesives (1) | mucodhesive (1) | Mulberry (1) |
| multi granules (1) | multidrug resistant pathogens (1) | Multikinase Inhibitor (1) |
| multiparticulates (1) | multiparticulates dosage form (1) | Multiple myeloma (1) |
| multiple regression (1) | multiple regression analysis (1) | Multitargeted drug (1) |
| Murraya koenigii L.Sprengel S.mutans (1) | Mycobacterium tuberculosis. (1) | Mycophenolate mofetil (1) |
| Mycophenolic acid (1) | Myeloperoxidase (1) | myocardial infarction (1) |
| Myomectomy. (1) | Myrica esculenta (1) | Myristicin (1) |
| Myrobalan (2) | N-aminoimidazoles (1) | N-napthyl ethylene diamine dihydrochloride (1) |
| Na+/K+-Atpase (1) | NABP (1) | NACO. (1) |
| Nadi shuddhi pranayama (1) | Naftopidil (1) | Naltrexone (2) |
| nano size (1) | Nanoemulsion (1) | Nanoformulation (2) |
| nanoformulations (1) | Nanonization. (1) | Nanopacticle (1) |
| Nanoparticle (1) | Nanoparticles (9) | Nanosuspension (1) |
| Nanosuspension tablets (1) | Nanosuspensions (1) | Naphthoquinone derivative (1) |
| NAPLEX (1) | naproxen (1) | Naranjo (1) |
| Naranjo algorithm (2) | Naranjo algorithm. (1) | Naranjo’s ADR probability scale (1) |
| Narikel Lavan (1) | Narrow therapeutic index drugs (1) | Nasal gel (1) |
| Nateglinide (1) | National Fomulary (1) | National Formulary (2) |
| National Health and Morbidity Surveys (1) | National Public Health Programs (1) | Natural (1) |
| natural compounds (3) | Natural deep eutectic solvent (1) | Natural Polymers (1) |
| natural products (3) | NCC-PvPI; Hepatitis B vaccine; ADR/AE; VigiFlow; system organ class (SOC) (1) | Nebivolol (2) |
| nebivolol hydrochloride (1) | Necrosis. (1) | need assessment (1) |
| Nephroprotective (3) | Nephrotic syndrome (1) | Nephrotoxicity (1) |
| Nerium indicum (1) | neuropathy (1) | Neurosurgical (1) |
| neutropenia (1) | nevirapine (1) | new molecule (1) |
| Newborns (1) | Nicorandil (1) | Nicotine (1) |
| Nicotine dependence (1) | Nifedipine. (1) | Nigeria. (1) |
| nigrostriatal pathway (1) | Nil (8) | Nill (18) |
| niosome (1) | Niosomes (1) | Nitric acid (1) |
| Nitric oxide (3) | Nitrogen starvation (1) | NK cell (1) |
| NMDA (1) | NMDA receptors (1) | Nodular skin lesions (1) |
| Non-linear (1) | non-prescription medicine use (1) | Non-steroid anti-inflammatory (1) |
| Non-steroidal anti-inflammatory drugs (1) | Non-surgical endodontic therapy. (1) | nonamers. (1) |
| noncommunicable disease (1) | noncompliance (1) | Nonionic surfactants (1) |
| nootropic (1) | Norfloxacin (1) | Normoglycemic rats (1) |
| northeast India (1) | Nose to brain delivery (1) | Nothopanax scutellarium (1) |
| NSAIDs (1) | Nuclear medicine (1) | nuclear pharmacy (1) |
| Nucleo CMP (1) | Nude mice (1) | Nutmeg oil (1) |
| Nutraceuticals (1) | Nutrient starvation (1) | Nutrition (1) |
| Nystagmus Phenytoin toxicity (1) | O-Phenylene diamine (1) | Obesity (2) |
| Occupational health (1) | Ocimum gratissimum (1) | Off-label (1) |
| offending drugs (1) | Okra Mucilage (1) | Olmesartan (1) |
| olmesartan medoxomil (1) | Omega-6 fatty acid (1) | Omeprazole. (1) |
| Omics (1) | Oncology. (1) | ondansetron (3) |
| ondansetron hydrochloride (1) | Online health screening (1) | Online pharmacies (1) |
| OPD – Outpatient Department. (1) | open field (1) | Ophthalmic (1) |
| ophthalmic delivery (1) | ophthalmic inserts (1) | Opinion (1) |
| Opportunities (1) | Opportunity (1) | Optimal stress (1) |
| optimization (7) | Oral bacteria (1) | Oral cancer (2) |
| oral disintegrating tablets (1) | Oral glucose tolerance (1) | oral glucose tolerance test (3) |
| Oral hypoglycemic drugs (1) | oral insulin (1) | Oral Rehabilitation (1) |
| Oral Surgery (4) | Organ Toxicities (1) | organic acids (1) |
| organogel (1) | Organophosphate (1) | Origanum vulgare (1) |
| Original Article (3) | Originator. (1) | Orlistat (1) |
| orodispersible tablet (1) | orodispersible tablets (2) | Oscillopsia (1) |
| Osmotic pump (1) | Osteoarthritis (1) | Osteoblast (2) |
| Osteoclast (1) | OTC switch (1) | Otomycosis (2) |
| Outdoor patients (1) | Outpatients (1) | ovalbumin (1) |
| Ovarian (1) | Ovarian Cyst (1) | Over-the-counter (1) |
| Overweight (1) | OVX (1) | oxazepinone (1) |
| oxcarbazepine (1) | Oxidation (1) | oxidative damage (1) |
| oxidative stress (6) | Oxyresveratrol (2) | oxytetracycline (1) |
| P-dimethylaminobenzaldeyde (1) | P-drug. (1) | P-drugs (1) |
| P-glycoprotein (1) | P. dulce (Fabaceae) (1) | p53 tumor suppressor gene (1) |
| Package insert (1) | Paediatric (2) | Pain (2) |
| Pain. (1) | Painkiller (1) | pair wise procedures (1) |
| Pakistan (2) | Pakistan. (4) | Paliperidone palmitate (1) |
| Pancreatitis. (1) | Pantoprazole (1) | papain (1) |
| Papain. (1) | PAR-2 receptor (1) | para-diaminobenzaldehyde (1) |
| paracetamol (3) | Paracetamol. (2) | Parkinson’s disease (1) |
| partial least square (1) | particle size analysis (1) | PASS (1) |
| passive avoidance learning (1) | Patch (1) | patents (2) |
| Pathological response (1) | Patient (2) | Patient adherence. (1) |
| patient counseling (1) | Patient counseling and Patient information leaflet (1) | patient education (1) |
| Patient health questionnaire (PHQ) (1) | Patient satisfaction (1) | Patient Survival (1) |
| patient-physician communication (1) | Patient-safety (1) | patients (5) |
| Patients. (1) | paw edema (1) | Paw edema. (1) |
| Paw volume (1) | PE 18:0/18:0-PEG 2000 (1) | Pectin (1) |
| pedagogy (1) | Pediatric (3) | Pediatric cancer (1) |
| Pediculosis (1) | Pegagan extract (1) | PEGylation (1) |
| Pemphigus vulgaris (1) | Penang (1) | penetration (3) |
| penetration enhancer (1) | penetration pressure (1) | penicillamine (1) |
| Penicillins (1) | pentylenetetrazole (1) | PEO (1) |
| Peperomia pellucida (L) Kunth (1) | Peperomia pellucida (L.) Kunth (3) | Peppas and Higuchi’s equations (1) |
| Peptic Ulcer. (1) | peptide vaccine (1) | Peptidoglycan (1) |
| percentage healing of wound area (1) | perception (5) | Periauricular tags. (1) |
| pericyclic fiber (1) | Periodontal disease (1) | periodontal diseases (1) |
| Periodontal dressing (1) | periodontal pocket (1) | Peripheral Neuropathy (1) |
| Permanent (1) | Permeation (2) | Peroxisome proliferator-activated receptorg (PPAR-γ) agonists (1) |
| Persistent ulcer (1) | Personal care products (2) | Persons and items reliability (1) |
| pH dependent approach (1) | pH independence (1) | pH-sensitive (1) |
| Phaleria marcocarpha (1) | Pharm. D. Integrated (1) | Pharm. D. Post Baccalaureate. (1) |
| pharma counseling (1) | pharmaceutical (1) | pharmaceutical advertisements (1) |
| Pharmaceutical care (2) | Pharmaceutical Care service (1) | pharmaceutical care. (1) |
| pharmaceutical formulations (1) | Pharmaceutical Marketing (1) | Pharmaceutical Services (1) |
| Pharmaceutical-Care (1) | Pharmaceutical-industries (1) | Pharmacist (4) |
| Pharmacist intervention. (1) | pharmacist role in public health (1) | Pharmacists (2) |
| pharmacists India (1) | Pharmacodynamic (3) | Pharmacodynamic activity (1) |
| pharmacodynamics (2) | Pharmacogenetics (1) | Pharmacogenomics (1) |
| pharmacognostic standardization (1) | pharmacognostical (1) | pharmacognosy study (1) |
| Pharmacokinetic (5) | Pharmacokinetic interactions. (1) | pharmacokinetics (8) |
| Pharmacokinetics. (2) | Pharmacological properties (1) | Pharmacophore (3) |
| Pharmacovigilance (15) | Pharmacovigilance Programme of India (1) | Pharmacovigilance. (1) |
| Pharmacovigilante’s (1) | Pharmacovigillance (1) | pharmacy (5) |
| pharmacy curriculum (2) | Pharmacy education (1) | Pharmacy Enforcement Division (1) |
| Pharmacy informatics (1) | Pharmacy intervention (1) | Pharmacy services (1) |
| Pharmacy store (1) | Pharmacy students (1) | Phase diagrams (1) |
| Phase I studies (1) | Phase rule (1) | phase solubility (1) |
| phase solubility profile (1) | Phenobarbitone (1) | Phenolic (1) |
| phenolic compounds (2) | phenolics (1) | phenols (1) |
| Phenothiazine (1) | Phenytoin (2) | Phenytoin cold cream (1) |
| Phenytoin Toxicity (1) | Pheritima posthuma (1) | Phleboliths (1) |
| Phoenix dactylifera (1) | Phosphorylase kinase (1) | Photoprotection. (2) |
| Phthalates (1) | Phyllanthus emblica, (1) | Phylogenetic tree (1) |
| Phylogeny (1) | Physical fitness (1) | Physical stability (1) |
| Physichochemical Characterization (1) | Physicians (4) | Physicochemical (1) |
| physicochemical evaluation (1) | physicochemical properties (1) | physiochemical descriptor (1) |
| Physiological role (1) | Phytochemical (2) | phytochemical prospection (1) |
| Phytochemical screening (1) | Phytopharmaceutical drug (1) | Phytosome (1) |
| picrotoxin (1) | pictograms (1) | Pilgrims (1) |
| PIM (1) | Pinus merkusii (1) | pioglitazone (1) |
| piperazine citrate (1) | Piperine (2) | Piroxicam (2) |
| Pits and Fissures (1) | Pixel intensity. (1) | Plackett-Burman (1) |
| Plackett-Burman design (1) | plant extracts (1) | plasma (3) |
| Plasma concentration (1) | plasma concentrations (1) | Plasma creatinine (1) |
| Plasma insulin (1) | Plasma urea (1) | plasma-brain correlation (1) |
| Plasma. (1) | Plasmodium falciparum 3D7 (1) | Plasmodium falciparum. (1) |
| Platelet aggregation. (1) | Platelet rich fibrin membrane. (1) | Pleiotropic effects (1) |
| PLGA (1) | PLSR (1) | Pluronic F 127 (1) |
| PM6 (1) | PM7 (1) | Pneumonia (2) |
| Point-measure correlation coefficients (1) | Poison (2) | Poisoning pattern (1) |
| Polarography (1) | Poloxamer 188 (1) | Poloxamer 407 (2) |
| Poloxamer 407. (1) | poly (lactic-co-glycolic acid) (1) | Poly herbal (1) |
| poly(ε-caprolactone) (1) | Poly-herbal (1) | polycaprolactone (1) |
| Polycystic Ovary Syndrome (1) | Polyelectrolyte complex (PEC) (1) | PolyElectrolytecomplex (1) |
| Polyethylene glycol (1) | Polyherbal (1) | polyherbal formulation (3) |
| Polymeric nanoparticles (2) | polypharmacy (7) | polypharmacy in diabetes mellitus. (1) |
| polyphenols (1) | Polysaccharide (1) | polyvinyl alcohol (2) |
| polyvinyl pyrrolidone (1) | Polyvinylpyrrolidone (1) | Polyvynil pyrrolidone (1) |
| Pomalidomide (1) | PON1 mRNA (2) | porosity (1) |
| Port-A Catheter. (1) | Portfolio (1) | Positive and Negative stressors (1) |
| Positive coping strategies. (1) | Posology (1) | Possible mechanisms (1) |
| Posterior reversible encephalopathy syndrome (1) | Potassium (1) | Potassium Channel (1) |
| Potassium chloride (1) | Potassium Nitrate (1) | Potential Drug-Drug Interaction (1) |
| PPAR agonists (1) | PPARγ agonists. (1) | PPBG (1) |
| pPharmacokinetics (1) | PPP model (1) | practice (3) |
| practices (1) | pravastatin (1) | Pre ADMET (1) |
| pre prandial (1) | Pre University students (1) | Pre-authorization (1) |
| Prebiotic (2) | Precipitation (1) | precise (1) |
| Precision (1) | Predictors (1) | Pregabalin (1) |
| Pregnancy (3) | preliminary screening (1) | Premna esculenta (1) |
| prescriber (1) | Prescribing (1) | Prescribing errors (1) |
| Prescribing pattern. (1) | Prescription (3) | Prescription error. (1) |
| prescription monitoring (1) | prescription only medicines (1) | Prescription pattern (2) |
| Prescription refill (1) | Prescription review (1) | pressure dependent approach (1) |
| Prevalence (3) | Primary health care (2) | Primary Health Care. (1) |
| Principal component analysis (1) | principal component regression (1) | Pristane (1) |
| Private Medical College (1) | PRO (1) | Probable (1) |
| Probiotic (1) | Probiotics (1) | Problem-based learning (1) |
| process capability (1) | Process parameters. (1) | Products with Antimicrobial Action. (1) |
| progesterone (1) | Proniosomal gel (1) | propolis (2) |
| Proportional reporting ratio (1) | propranol hydrochloride (1) | Propranolol hydrochloride (1) |
| Prospective Study (2) | prostaglandins (1) | Prosthesis Coloring (1) |
| Proteasome activity (1) | protein proÞ le (1) | proteolytic enzymes (1) |
| Proton adduct (1) | Proton Pump Inhibitor (2) | Proton-pump Inhibitors (1) |
| Protransfersome (1) | Prteomics (1) | Pseudo ternary phase diagrams (1) |
| Pseudomonas aeruginosa (1) | Psidium Guajava (1) | Psychological mindedness (1) |
| Psychomotor (1) | Psychosis (2) | Psychotropic drugs (1) |
| Psychotropics (1) | Pterocarpus indicus (1) | Pterocarpus indicus Willd (1) |
| Public behavior (1) | Public health hospital (1) | Public hospital (1) |
| Publication (1) | Publications (2) | Pulmonary Fibrosis (1) |
| pulmonary hypertension (1) | Pulmonary toxicity (1) | Punica granatum (1) |
| pyrazine (1) | pyrazoline (1) | pyrazolines (1) |
| Pyrimidine (1) | Q1F (1) | QOL (1) |
| QSAR (2) | qualitative (1) | Qualitative analysis (1) |
| qualitative study (1) | Quality (1) | quality assurance (1) |
| Quality Control (1) | Quality Indicators (1) | quality of internet information (1) |
| quality of life (6) | quantitative structure-activity relationship (1) | Quercetin (2) |
| quinazolin-4(3H)one (1) | quinazolinone (1) | Quinazolinone. (1) |
| quinoline derivatives (1) | R2 values (1) | Rabbit plasma (2) |
| Rabbits. (1) | radical scavenger (1) | radicals (1) |
| Radiology Unit (1) | radiopharmaceuticals (1) | radiopharmacy (1) |
| Radioprotective (1) | Raillietina echinobothrida (1) | raloxifene hydrochloride (1) |
| Raman spectroscopy (2) | ramipril (2) | ranitidine (1) |
| Ranitidine hydrochloride (2) | Ranitidine’. (1) | ranolazine (1) |
| Ransmission electron microscopy (1) | Rapid disintegration (1) | Rasagiline mesylate (1) |
| Rat (1) | ratio test procedures (1) | Rational pharmacotherapy. (1) |
| Rational prescribing (1) | Rational use of medicine (1) | rational use of medicines (1) |
| rats (1) | Rattus novergicus (1) | Re-emerging viral infections (1) |
| re-precipitation (1) | recognized standards (1) | recovery studies (1) |
| Red ginger (1) | Reduction (2) | Reflective pedagogy paradigm (1) |
| reforms (1) | Regeneration (1) | Regression analysis (1) |
| Regressions statistics (1) | Regulation (1) | Regulations (1) |
| regulatory (2) | Regulatory affairs (1) | regulatory system (1) |
| Relative performance (1) | release kinetics (3) | Release studies. (1) |
| relese kinetics (1) | Removable denture (1) | Renoprotection (1) |
| Renoprotective (1) | repaglinide (2) | reperfusion (1) |
| Repurposing (1) | research (1) | Research Skills. (1) |
| reserpine (1) | Resident doctors (1) | Resistance (3) |
| Resistant starch (1) | Resource poor setting (1) | Respiratory tract (1) |
| Response Surface Methodology (1) | Response surface methodology. (1) | Response to antiretroviral therapy (1) |
| Resveratrol (2) | retail pharmacy (1) | Retention. (1) |
| Retinopathy (1) | retrospective cohort (1) | Retrospective study (2) |
| reversed-phase chromatography (1) | Rhabdomyolysis (1) | Rhaphidophora pinnata (1) |
| rhizomes (1) | Riboflavin (1) | Rice Bran Oil (1) |
| Rifampicin (1) | Ringer’s dextrose (1) | Ringer’s lactate. (1) |
| Riociguat (1) | Risk factor. (1) | Risk factors (2) |
| Risk Factors. (1) | Risk rating (1) | Rituximab (1) |
| rivastigmine (1) | RNAi (1) | RNAi technology (1) |
| RNTCP (1) | Rodenticides (1) | root (1) |
| Root canal infection (1) | Roots extract (2) | Ropinirole (1) |
| rosuvastatin (2) | rosuvastatin calcium (1) | Royal Malaysian Custom Officer (1) |
| RP-HPLC (7) | RP-HPLC method (1) | RP-TLC/Densitometry (1) |
| RT-qPCR (1) | Rubus fraxinifolius (1) | Rubus rosifolius (1) |
| rupatadine (1) | rutin (1) | ß avonoids (2) |
| S. mutans (1) | S.salivarius (1) | S.sanguis (1) |
| Saccharin (1) | Safe handling guidelines (1) | Safety (1) |
| Safoof-e- Binai (1) | Sage (1) | Saponin (1) |
| saponins (1) | Sappan wood (1) | Saraschandra (1) |
| Satisfaction (2) | Saudi Arabia (1) | Saussurea (2) |
| Saussurea lappa (1) | scanning electron microscopy (3) | Schizophrenia (1) |
| Scientific Advertisements (1) | Scientometrics (3) | sclerotherapy (1) |
| Scores. (1) | Se- DeM ODT Expert system (1) | Second-line agents (1) |
| Secondary Level (2) | seizure outcome (1) | Seizures (1) |
| Selected area electron diffraction (1) | Self medication (1) | self-emulsifying drug delivery system (1) |
| Self-Harm (1) | self-medication (5) | self-nanoemulsification (1) |
| Semi-permanent hair dye (1) | senna spectabilis (1) | Sensitive (1) |
| sensory cortical activity. (1) | separation (1) | sepbox (1) |
| Septic shock (1) | Sequences distillation (1) | Sequential optimization (1) |
| Serum (1) | Serum Ferritin (1) | Serum Glutamate-Pyruvate Transaminase (1) |
| Serum Glutamic Oxaloacetic Transaminase (1) | Serum triglyceride (1) | Serum Vitamin D (1) |
| Serum. (1) | sesame oil (1) | severe febrile neutropenia (1) |
| Severe sepsis (1) | Severity (2) | Sexual dysfunction in diabetes (1) |
| Shodhana (1) | Short Communication (3) | short-term memory (1) |
| Sida rhomboidea.Roxb (1) | Side effect (1) | signal detection (1) |
| Signal detection. (1) | Signs and Symtoms (1) | Silver nanoparticles (1) |
| silymarin (1) | similarity factor (f2) (2) | simplex lattice (1) |
| Simplex Lattice Design (2) | simultaneous determination (2) | simultaneous extraction (1) |
| simvastatin (1) | simvastatin. (1) | Single nucleotide polymorphism (1) |
| sintering (1) | siRNA (1) | siRNA. (2) |
| SIRT1 (1) | Sirtuin (1) | six sigma (1) |
| SJS (1) | Skin whitening (1) | SLAM markers (1) |
| SLS (1) | Smix. (1) | Smoking (1) |
| smoking cessation. (1) | Smoking. (1) | smooth muscle cells (1) |
| Snake bite (1) | SNEDDS (2) | sobatum (1) |
| Social Media (1) | Social sexual. (1) | Socioeconomic status (1) |
| SOD (1) | Sodium (1) | sodium alginate (1) |
| sodium alginate. (2) | sodium carboxy methyl cellulose (1) | sodium starch glycolate (3) |
| Sodium starch glycolate (SSG) (1) | Sodium Valproate (1) | Solanum nigrum (1) |
| Solanum trilobatum (1) | Solanum viarum (1) | Solanum xanthocarpum, (1) |
| Solasodine (1) | solid dispersion (5) | solid lipid nanoparticles (1) |
| Solid lipid nanoparticles. (1) | Solid Phase Extraction (1) | solubility (5) |
| Solubility enhancement (1) | Solubility. (1) | solvent casting (1) |
| solvent evaporation (3) | Solvent evaporation. (1) | sonication time (1) |
| sonophoresis (1) | Sorafenib (1) | Spacedrepetition. (1) |
| spasmolytic (1) | speciÞ city (1) | Spectrometric (1) |
| spectrophotometry (2) | sperm count (2) | SPF (1) |
| Spiro compounds (1) | Spleen colony assay (1) | Sponge implantation (1) |
| sponge implantation assay (1) | sponsors (1) | Spontaneous-Reporting. (1) |
| Sprague Dawley (1) | spray drying (1) | SPSS 20. (1) |
| ST segment elevation (1) | stability (1) | stability indicating (1) |
| stability indicating and validation. (1) | Stability indicating assay (1) | Stability indicating assay method (1) |
| stability indicating method of artemether (1) | stability indicating. (1) | Stability of the physical properties (1) |
| Stability test (1) | stability. (1) | stain removal (1) |
| stakeholders (1) | Standardization (5) | Standardized Zscore (1) |
| Staphylococcus aureus (1) | Starlac (1) | Statin pathway (1) |
| Statins. (1) | Statistical Modeling (1) | Statistical optimization (1) |
| Stelechocarpus burahol (1) | Stem bark extract (1) | Stephania hernandifolia (1) |
| Stereospermum suaveolens (1) | Stereospermum tetragonum (2) | Sterilization Procedures (1) |
| Steroidal alkaloid (1) | Steudnera colocasiifolia (1) | Stevens-Johnson syndrome (1) |
| Stilbene (1) | Stimulantia (1) | Stimuli (1) |
| Stomatitis under prosthesis (1) | Streptococci (1) | Streptococcus mutans (2) |
| Streptokinase (1) | Streptomonospora arabica (1) | Streptomyces (1) |
| Streptozotocin (2) | Streptozotocin (STZ) (1) | streptozotocin-induced diabetes (1) |
| Streptozotocin. (1) | stress (3) | stress studies (2) |
| stroke and cardiac pacemaker. (1) | Stroke prevention (1) | structural descriptor (1) |
| Structured Communication. (1) | Stryphnodendron rotundifolium (1) | students (3) |
| students’ residence (1) | Sub Clinical Hypothyroidism. (1) | Sub-acute Inflammation (1) |
| Subcutaneous fat (1) | sublingual films (1) | substituted acetophenones (1) |
| sucrase (1) | Sudan (1) | Sulfonylurea (2) |
| Sulfonylureas (1) | Sulphorhodamine-B (1) | Sun (1) |
| sun protection factor (2) | Sunlight (1) | Sunscreens. (1) |
| Super disintegrants (1) | superdisintegrants (2) | Superdisintergrants (1) |
| Superoxide Dismutase. (1) | superoxidedismutase (1) | superporous hydrogel composite (1) |
| Supply Chain Management (1) | support staff. (1) | Surface properties (1) |
| surfactant (1) | surfactants (1) | Surgical cutters (1) |
| surgical prophylaxis. (1) | Surgical. (1) | Survey questionnaire (1) |
| survey. (1) | Survival rate (1) | sustained release (3) |
| sustained release pellets (1) | sustained release. (1) | Sweet orange peel extract (Citrus sinensis) (1) |
| swelling index (1) | swelling studies (1) | SWOT (1) |
| Symptoms (1) | Synchronous spectrofluorimetry. (1) | Synergism. (1) |
| Synthesis (2) | Synthesis; 1-allyl-3-benzoylthiourea; COX-2; Analgesic; Lead Compound; (1) | Systematic Review. (1) |
| Systemic steroids. (1) | Systems biotechnology (1) | Systolic dysfunction. (1) |
| T cell epitope (1) | T regs (1) | Tab. Pardopa (1) |
| Tablet Compression (1) | Tacrolimus (1) | Tacrolimus Once Daily (1) |
| Tacrolimus Twice Daily. (1) | Tactile stimulation (1) | tail suspension test (1) |
| Tamarindus indica (1) | Tamilians (1) | Tamoxifen (1) |
| Target delivery (1) | Targeted drug delivery system (1) | taste masking (2) |
| tasteless complex (1) | taxane (1) | Taxanes (1) |
| Taxus baccata (1) | Teaching Hospital (1) | Technology (1) |
| technology-enhanced learning (1) | tegument (1) | telmisartan (1) |
| Temporomandibular Joint Disoders (1) | TEN (1) | Tenofovir disoproxil fumarate (1) |
| Tephrosia purpurea ethanolic seed extract (TpEt). (1) | Terminalia bellirica (1) | Termineliachebula;Plants; Galls;Albendazole; anthelmintic; Drug. (1) |
| Ternary phase diagram (1) | terpenoids (1) | Tertiary Care (1) |
| Tertiary care hospital (2) | testicular damage (1) | testosterone (3) |
| Tetrapreniltoluquinone (1) | thalassemia major (1) | therapeutic angiogenesis (1) |
| therapeutic dose (1) | therapeutic drug monitoring (2) | therapeutic effectiveness (1) |
| Thermoreversible gel (1) | Third Molar (4) | Thixogel (1) |
| THP-1 (2) | Three component system (1) | thrombocytopenia (1) |
| Thrombolysed subjects (1) | Thrombolytic (1) | thrombolytic enzymes (1) |
| Thyme oleoresin (1) | Thyrotoxicosis. (1) | time dependent approach (1) |
| Time lag (1) | Timed release (1) | Tobacco (2) |
| Tobacco smoking (1) | tolbutamide (1) | Tolerance (1) |
| Tooth brush. (1) | Toothpaste (1) | Toothpaste. (1) |
| Topical delivery. (1) | Topical. (1) | Total flavonoid (1) |
| Total flavonoid content (2) | Total phenolic (2) | Total phenolic content (1) |
| total polyphenolic content (1) | total quality management (1) | toxicity (5) |
| Toxicity. (2) | traditional medicine (2) | Training of Central sterile and supply department employees (1) |
| tramadol HCL (1) | Tramadol Hydrochloride (1) | Trans-cinnamic acid (1) |
| Trans-resveratrol (1) | Transcriptomics. (1) | transdermal (2) |
| transfer latency (1) | Transfersome (2) | Transfersomes. (1) |
| Translation (1) | Transmucosal (1) | Transmucosal patch (1) |
| Trauma induced external inflammatory root resorption (1) | Treatment adherence. (1) | Treatment outcomes (1) |
| Treatment success rate (1) | Triacylglycerol. (1) | Triamcinalone Acetonide (TRIA) (1) |
| Trichoderma reesei. (1) | Tricyclic antidepressants (TCA) (1) | Triglycerides (1) |
| Trigonella foenum graecum (1) | Trigonelline (1) | Trinidad & Tobago (1) |
| trinitrobenzene sulfonic acid (1) | Triphala (1) | triple distilled water (1) |
| Triterpenoid. (1) | Triterpenoids (1) | Triticum aestivum. (1) |
| Tropaeolum majus L (1) | tropicamide (1) | Troponin-I (1) |
| Trypsin (1) | TSLP (1) | Tuberculosis (4) |
| Tuberculosis/HIV (1) | Tumor response (1) | Turkey (1) |
| Tween 80. (1) | Twisted (1) | Tylophora indica (1) |
| Tylophorinidine. (1) | type 2 diabetes (2) | Type 2 diabetes mellitus. (1) |
| type 2 diabetes. (1) | UACR (1) | UCPMP Guidelines (1) |
| Ultra-Fast Liquid Chromatography (UFLCDAD) (2) | Ultrasonic assisted extraction (1) | ultrasonication-solvent evaporation technique (1) |
| Ultrasonography (1) | Unani medicine (4) | Uncemented (1) |
| Underutilization of insulin. (1) | Unethical practices. (1) | Unique device identification (1) |
| Universities (1) | Unlicensed. (1) | Unnecessary use. (1) |
| Unused/Unwanted medicines (1) | UPLC/ESI-Q-TOF-MS/MS method Validation (1) | Urban area (1) |
| urea (2) | Uremic toxins (2) | Urinary Hydrogen Peroxide (1) |
| Urinary tract infection (UTI) (1) | Urine Albumin to Creatinine Ratio (1) | Urine volume (1) |
| urolithiasis (1) | Urtica dioica L (1) | Usefulness. (1) |
| Uterine fibroid (1) | Uterine Perforation. (1) | UV derivative spectrophotometry (1) |
| UV detection (2) | UV Spectrophotometric method (1) | UV spectrophotometry (1) |
| UV-spectrophotometric method (1) | UV-spectrophotometry (2) | UV-Vis spectroscopy (1) |
| Vaccine (1) | Vaccine design (1) | vada (1) |
| vaginal gel (1) | Vaginitis. (1) | Vakrasana (1) |
| validation (18) | Valium (1) | Valproate (1) |
| valsartan (1) | Vanillin (1) | Vanillosmopsis arborea. (1) |
| vascular bundle (1) | vascular permeability (2) | vascular progenitors (1) |
| VED analysis (3) | VED analysis. (2) | VEGFR-2 (1) |
| Venetoclax (1) | Venography and Hemangioma (1) | Venous malformations (VMs) (1) |
| verapamil (3) | Verapamil HCl (1) | Viability (1) |
| Vincristine. (1) | Vinegar (1) | VIPPS (Verified Internet Pharmacy Practice Sites) (1) |
| Virtual Screening (1) | Viscosity (1) | visible Spectrophotometry (1) |
| visible spectroscopy (1) | Visual analogue scale. (1) | Vitamin D (3) |
| Vitamin D deficiency (1) | Vitamin D. (1) | vitamin E (1) |
| vitamin E d-α-tocopheryl polyethylene glyco1000 succinate (1) | Vitamin. (1) | Vitex agnus Castus (1) |
| Voltage–gated calcium channels (1) | warfarin (2) | Warning signs (1) |
| Water hyacinth (2) | web-based learning (1) | Weibull parameters (1) |
| West timor (1) | Western blot technique (1) | Wet gangrene (2) |
| wet granulation (1) | wetting time (1) | Wheat (1) |
| White/red patch (1) | WHO-QOL BREF questionnaire (1) | WHO-UMC causality assessment system. (1) |
| Wilson disease (1) | Wistar rats. (1) | Withania somnifera. (1) |
| Withdrawal (1) | Women. (1) | Work protection (1) |
| World Health Organization (1) | Wound Healing (1) | Wound tissue healing (1) |
| Wrightia tinctoria (1) | writhing (1) | X-ray diffraction (1) |
| X-ray imaging study. (1) | X-ray powder diffraction (1) | xanthan gum (1) |
| Xanthangum (1) | XDR-TB (1) | Xenografts (1) |
| Xenografts. (1) | XRD (1) | Ylang-ylang (1) |
| Yoga (1) | Yucca gloriosa L. (1) | Zea m1 pollen allergen (1) |
| Zero order release (1) | zero order spectrophotometry (1) | zeta potential (1) |
| zidovudine (1) | Zika virus (1) | zinc (1) |
| Zinc ion (1) | Zingiber officinale (1) | Zingiberaceae (1) |
| zopiclone (1) | [BMIM]PF6 (1) | Þ rst-order derivative spectroscopy (1) |
| Α-amylase (2) | α-glucosidase (1) | α-mangostin (1) |
| β Amyloid1-42 (1) | β-carboline (1) | β-carotene production (1) |
| β-cyclodextrin (3) | γ-oryzanol (1) | ε-amino groups (1) |
